Genprex (GNPX) Short Interest Ratio & Short Volume $0.27 -0.01 (-3.63%) As of 12:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Genprex Short Interest DataGenprex (GNPX) has a short interest of 2.56 million shares, representing 10.90% of the float (the number of shares available for trading by the public). This marks a 57.06% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 3.81 million shares to cover all short positions.Current Short Interest2,560,000 sharesPrevious Short Interest1,630,000 sharesChange Vs. Previous Month+57.06%Dollar Volume Sold Short$742,400.00Short Interest Ratio0.6 Days to CoverLast Record DateApril 30, 2025Outstanding Shares27,821,000 sharesFloat Size23,490,000 sharesShort Percent of Float10.90%Today's Trading Volume583,392 sharesAverage Trading Volume3,805,649 sharesToday's Volume Vs. Average15% Short Selling Genprex? Sign up to receive the latest short interest report for Genprex and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNPX Short Interest Over TimeGNPX Days to Cover Over TimeGNPX Percentage of Float Shorted Over Time Genprex Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20252,560,000 shares $742,400.00 +57.1%10.9%0.6 $0.29 4/15/20251,630,000 shares $423,800.00 +487.6%6.9%0.4 $0.26 3/31/2025277,400 shares $68,046.22 -16.9%1.2%0.1 $0.25 3/15/2025333,600 shares $121,196.88 -47.3%4.0%0.2 $0.36 2/28/2025633,100 shares $238,678.70 -44.0%7.7%0.7 $0.38 2/15/20251,130,000 shares $498,217.00 +505.3%13.7%1.2 $0.44 1/31/2025186,700 shares $115,492.62 -28.6%2.3%0.2 $0.62 1/15/2025261,300 shares $182,910.00 -34.0%3.2%0.1 $0.70 12/31/2024396,100 shares $337,318.76 -37.6%4.8%0 $0.85 12/15/2024634,600 shares $736,136.00 +46.5%7.7%0.1 $1.16 Get the Latest News and Ratings for GNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genprex and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024433,100 shares $472,079.00 +26.6%5.4%0 $1.09 11/15/2024342,100 shares $547,360.00 -5.9%4.3%0 $1.60 10/31/2024363,400 shares $817,650.00 +326.5%15.0%0 $2.25 10/15/202485,200 shares $28,490.88 +5.2%3.5%0 $0.33 9/30/202481,000 shares $29,297.70 -66.9%3.3%0.2 $0.36 9/15/2024244,700 shares $102,774.00 +501.2%9.6%0.6 $0.42 8/31/202440,700 shares $27,873.40 -83.6%1.6%0.1 $0.68 8/15/2024247,400 shares $161,280.06 +430.9%9.7%1.1 $0.65 7/31/202446,600 shares $78,288.00 -16.6%2.3%0.5 $1.68 7/15/202455,900 shares $111,800.00 +10.5%2.7%0.6 $2.00 6/30/202450,600 shares $95,381.00 -39.2%2.5%0.5 $1.89 6/15/202483,200 shares $180,544.00 +75.9%4.0%0.8 $2.17 5/31/202447,300 shares $147,103.00 +20.1%2.3%0.4 $3.11 5/15/202439,400 shares $96,136.00 -21.2%1.9%0.8 $2.44 4/30/202450,000 shares $113,000.00 +0.6%2.5%0.9 $2.26 4/15/202449,700 shares $119,280.00 -29.0%2.7%0.6 $2.40 3/31/202470,000 shares $208,600.00 -12.8%3.8%0.8 $2.98 3/15/202480,300 shares $324,412.00 +23.7%5.6%1 $4.04 2/29/202464,900 shares $279,070.00 -35.3%4.5%1 $4.30 2/15/2024100,300 shares $439,314.00 +86.1%6.9%2 $4.38 1/31/202453,900 shares $409,640.00 +38.6%3.7%1.1 $7.60 1/15/20241,560,000 shares $339,768.00 +13.9%N/A4.2 $0.22 12/31/20231,370,000 shares $315,100.00 +25.7%N/A3.6 $0.23 12/15/20231,090,000 shares $229,990.00 -7.6%N/A3.3 $0.21 11/30/20231,180,000 shares $285,560.00 -11.9%N/A4 $0.24 11/15/20231,340,000 shares $348,400.00 -18.3%N/A4.5 $0.26 10/31/20231,640,000 shares $362,440.00 -8.9%N/A4.2 $0.22 10/15/20231,800,000 shares $585,000.00 +9.1%N/A4.2 $0.33 9/30/20231,650,000 shares $651,585.00 -6.8%N/A3.1 $0.39 9/15/20231,770,000 shares $901,815.00 +3.5%N/A2.5 $0.51AI Bloodbath Coming on June 1st? (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 8/31/20231,710,000 shares $888,687.00 -19.0%N/A2.4 $0.52 8/15/20232,110,000 shares $1.19 million -17.3%N/A2.8 $0.57 7/31/20232,550,000 shares $1.94 million +11.8%N/A3.9 $0.76 7/15/20232,280,000 shares $1.88 million -22.5%N/A3.8 $0.82 6/30/20232,940,000 shares $2.79 million +55.6%N/A4.7 $0.95 6/15/20231,890,000 shares $1.61 million -6.0%N/A4.5 $0.85 5/31/20232,010,000 shares $1.73 million +6.9%N/A4.4 $0.86 5/15/20231,880,000 shares $1.52 million -16.8%N/A3.4 $0.81 4/30/20232,260,000 shares $1.85 million +37.0%N/A4.1 $0.82 4/15/20231,650,000 shares $1.37 million -4.1%N/A3 $0.83 3/31/20231,720,000 shares $1.57 million -11.3%N/A5 $0.91 3/15/20231,940,000 shares $1.60 million -29.2%N/A4.8 $0.83 2/28/20232,740,000 shares $3.51 million +52.2%N/A7.5 $1.28 2/15/20231,800,000 shares $2.86 million +2.9%N/A5.7 $1.59 1/31/20231,750,000 shares $2.57 million +6.1%N/A9.4 $1.47 1/15/20231,650,000 shares $2.36 million +13.0%N/A9.6 $1.43 12/30/20221,460,000 shares $2.12 million -2.0%N/A8.7 $1.45 12/15/20221,490,000 shares $1.77 million -4.5%N/A13.9 $1.19 11/30/20221,560,000 shares $2.11 million +0.7%N/A15.8 $1.35 11/15/20221,550,000 shares $2.09 million -1.9%N/A12.8 $1.35 10/31/20221,580,000 shares $2.15 million -1.9%N/A6.1 $1.36 10/15/20221,610,000 shares $2.14 million -8.0%N/A6 $1.33 9/30/20221,750,000 shares $2.47 million -0.6%N/A6.7 $1.41 9/15/20221,760,000 shares $2.94 million -5.4%N/A6.8 $1.67 8/31/20221,860,000 shares $2.98 million +16.3%N/A7.2 $1.60 8/15/20221,600,000 shares $3.34 million -4.2%N/A6.6 $2.09 7/31/20221,670,000 shares $2.32 million -11.6%N/A15.1 $1.39 7/15/20221,890,000 shares $2.72 million +1.1%N/A16.3 $1.44 6/30/20221,870,000 shares $2.60 million +2.2%N/A13.9 $1.39 6/15/20221,830,000 shares $2.49 million -9.9%N/A12 $1.36 5/31/20222,030,000 shares $2.98 million +5.2%N/A10.1 $1.47 5/15/20221,930,000 shares $2.93 million -1.0%N/A7 $1.52 4/30/20221,950,000 shares $3.12 million -3.0%N/A5.6 $1.60 4/15/20222,010,000 shares $4.00 million +8.1%N/A3.5 $1.99 3/31/20221,860,000 shares $4.20 million -3.1%N/A1.4 $2.26 3/15/20221,920,000 shares $3.88 million -20.0%N/A0.3 $2.02 2/28/20222,400,000 shares $5.47 million -19.2%N/A0.4 $2.28 2/15/20222,970,000 shares $7.01 million -13.2%N/A0.5 $2.36 1/31/20223,420,000 shares $6.81 million -23.8%N/A0.6 $1.99 1/15/20224,490,000 shares $10.15 million +113.8%N/A0.7 $2.26 12/31/20212,100,000 shares $2.75 million -3.7%N/A0.4 $1.31 12/15/20212,180,000 shares $2.83 million -1.4%N/A5.1 $1.30 11/30/20212,210,000 shares $3.20 million -2.6%N/A5.4 $1.45 11/15/20212,270,000 shares $4.65 million -0.9%N/A5.7 $2.05 10/29/20212,290,000 shares $5.34 million +2.7%N/A6.1 $2.33 10/15/20212,230,000 shares $5.37 million -2.6%N/A5.7 $2.41 9/30/20212,290,000 shares $6.14 million -2.6%N/A6 $2.68 9/15/20212,350,000 shares $6.51 million +2.6%N/A4.8 $2.77 8/31/20212,290,000 shares $7.21 million -2.6%N/A4.3 $3.15 8/13/20212,350,000 shares $6.49 million -10.0%N/A4.1 $2.76AI Bloodbath Coming on June 1st? (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 7/30/20212,610,000 shares $7.73 million -6.5%N/A4.5 $2.96 7/15/20212,790,000 shares $8.15 million No Change6.6%4.5 $2.92 6/30/20212,790,000 shares $9.35 million -24.8%6.6%4 $3.35 6/15/20213,710,000 shares $13.21 million -7.3%8.8%5.1 $3.56 5/28/20214,000,000 shares $14.96 million -2.7%9.4%5.2 $3.74 5/14/20214,110,000 shares $12.78 million -1.4%N/A4.4 $3.11 4/30/20214,170,000 shares $16.30 million No ChangeN/A3.7 $3.91 4/15/20214,170,000 shares $16.97 million -3.9%N/A2.9 $4.07 3/31/20214,340,000 shares $17.66 million +24.4%N/A2.9 $4.07 3/15/20213,490,000 shares $18.43 million +9.8%N/A1.9 $5.28 2/26/20213,180,000 shares $16.89 million -2.8%N/A1.8 $5.31 2/12/20213,270,000 shares $22.82 million -22.0%N/A1.9 $6.98 1/29/20214,190,000 shares $18.73 million +3.7%N/A2.7 $4.47 1/15/20214,040,000 shares $15.47 million +27.0%N/A3.1 $3.83 12/31/20203,180,000 shares $14.06 million +0.6%N/A2.9 $4.42 12/15/20203,160,000 shares $10.40 million -6.2%N/A3.3 $3.29 11/30/20203,370,000 shares $10.41 million +12.3%N/A5.4 $3.09 11/15/20203,000,000 shares $9.48 million -1.0%N/A4.2 $3.16 10/30/20203,030,000 shares $10.70 million +2.0%N/A3.4 $3.53 10/15/20202,970,000 shares $10.96 million -5.7%N/A3.3 $3.69 9/30/20203,150,000 shares $10.58 million -9.2%N/A2.5 $3.36 9/15/20203,470,000 shares $13.12 million -8.9%N/A2.3 $3.78 8/31/20203,810,000 shares $15.09 million +7.3%N/A2.3 $3.96 8/14/20203,550,000 shares $15.23 million -9.9%N/A2 $4.29 7/31/20203,940,000 shares $13.28 million +1.8%N/A2.3 $3.37 7/15/20203,870,000 shares $11.46 million -4.2%N/A1.4 $2.96 6/30/20204,040,000 shares $12.69 million +24.3%N/A1.5 $3.14 6/15/20203,250,000 shares $9.82 million +6.9%N/A1.3 $3.02 5/29/20203,040,000 shares $8.42 million -24.6%N/A1.1 $2.77 GNPX Short Interest - Frequently Asked Questions What is Genprex's current short interest? Short interest is the volume of Genprex shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,560,000 shares of GNPX short. 10.90% of Genprex's shares are currently sold short. Learn More on Genprex's current short interest. What is a good short interest ratio for Genprex? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNPX shares currently have a short interest ratio of 1.0. Learn More on Genprex's short interest ratio. What is a good short interest percentage for Genprex? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.90% of Genprex's floating shares are currently sold short. Is Genprex's short interest increasing or decreasing? Genprex saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,560,000 shares, an increase of 57.1% from the previous total of 1,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Genprex's float size? Genprex currently has issued a total of 27,821,000 shares. Some of Genprex's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genprex currently has a public float of 23,490,000 shares. How does Genprex's short interest compare to its competitors? 10.90% of Genprex's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genprex: Annovis Bio, Inc. (13.70%), Allakos Inc. (0.37%), Kezar Life Sciences, Inc. (1.11%), Generation Bio Co. (2.47%), Surrozen, Inc. (0.90%), CalciMedica, Inc. (1.09%), Cyclacel Pharmaceuticals, Inc. (12.61%), Daré Bioscience, Inc. (0.62%), Tenax Therapeutics, Inc. (8.49%), CytoMed Therapeutics Limited (1.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Genprex stock? Short selling GNPX is an investing strategy that aims to generate trading profit from Genprex as its price is falling. GNPX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genprex? A short squeeze for Genprex occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNPX, which in turn drives the price of the stock up even further. How often is Genprex's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNPX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Annovis Bio Short Squeeze Allakos Short Squeeze Kezar Life Sciences Short Squeeze Generation Bio Short Squeeze Surrozen Short Squeeze CalciMedica Short Squeeze Cyclacel Pharmaceuticals Short Squeeze Daré Bioscience Short Squeeze Tenax Therapeutics Short Squeeze CytoMed Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNPX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genprex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genprex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNPX Stock Free GNPX Stock Alerts